https://scholars.lib.ntu.edu.tw/handle/123456789/533636
標題: | Current status of left main coronary angioplasty - Implication of drug-eluting stent | 作者: | Liu C.-P. Wu X.-M. HSIEN-LI KAO |
公開日期: | 2008 | 卷: | 19 | 期: | 6 | 起(迄)頁: | 454-464 | 來源出版物: | Journal of Internal Medicine of Taiwan | 摘要: | Traditionally, the treatment of choice for left main coronary artery disease (LMCA) was bypass surgery. With the advancement of the percutaneous coronary intervention (PCI) including technical breakthrough and development of drug-eluting stents (DES), the results of PCI in LMCA have improved significantly. Since 2006, several studies comparing PCI using drug-eluting stent and coronary artery bypass surgery have been published. Death, cerebrovascular events, and myocardial infarction rates in patients receiving DES treatment or bypass surgery are similar. The experience in Taiwan has also shown that the result of PCI for LMCA is not inferior to the published data. Despite these facts, there was a paucity of large randomized controlled trial. In addition, there is no consensus on the ideal interventional strategy for different types of LMCA. However, we may still anticipate revolutionary progress of LMCA treatment in the near future, and interventionalists will play a more and more important role with the evolving technology in new generation DES. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-58149508315&partnerID=40&md5=ea0a9e6fd607c19c8774cc1006e464ef https://scholars.lib.ntu.edu.tw/handle/123456789/533636 |
ISSN: | 1016-7390 | SDG/關鍵字: | acetylsalicylic acid; clopidogrel; everolimus; paclitaxel; rapamycin; zotarolimus; article; cerebrovascular disease; clinical trial; controlled clinical trial; coronary artery bypass surgery; coronary artery disease; coronary stent; death; drug eluting stent; heart infarction; human; in-stent restenosis; left coronary artery; medical decision making; medical research; outcome assessment; percutaneous coronary intervention; postoperative thrombosis; randomized controlled trial; Taiwan; transluminal coronary angioplasty; treatment outcome |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。